Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.4881
-0.0319 (-6.13%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $7.4 million as of July 24, 2026. Its market cap has decreased by -21.36% in one year.
Market Cap
7.40M
Enterprise Value
4.26M
1-Year Change
-21.36%
Ranking
Category
Stock Price
$0.49
ChartMarket Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $7.40M, a decrease of -98.19%. That is a compound annual growth rate of -26.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 7.40M | -18.10% |
| Dec 31, 2025 | 9.03M | -72.02% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aprea Therapeutics | 7.83M |
| CNS Pharmaceuticals | 7.64M |
| MetaVia | 7.64M |
| BioRestorative Therapies | 7.39M |
| Bolt Biotherapeutics | 7.36M |
| Processa Pharmaceuticals | 7.15M |
| Can-Fite BioPharma | 7.11M |
| Niki BioSolutions | 6.82M |